2018-21147. New Animal Drugs; Withdrawal of Approval of New Animal Drug Applications  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notification of withdrawal.

    SUMMARY:

    The Food and Drug Administration (FDA) is withdrawing approval of 12 new animal drug applications (NADAs) at the sponsor's request because these products are no longer manufactured or marketed.

    DATES:

    Withdrawal of approval is effective October 9, 2018.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Sujaya Dessai, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5761, sujaya.dessai@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Virbac AH, Inc., 3200 Meacham Blvd., Ft. Worth, TX 76137, has requested that FDA withdraw approval of the NADAs listed in the following table because the products are no longer manufactured or marketed:

    File No.Product name21 CFR section
    011-779PURINA PIGEMIA 100 (colloidal ferric oxide)522.1182
    040-205PURINA Horse Wormer Medicated (thiabendazole)520.2380a
    042-116PURINA 6 DAY WORM-KILL Feed Premix (coumaphos)558.185
    043-215PURINA GRUB-KILL Pour-on Cattle Insecticide (famphur)524.900
    046-700STATYL Medicated Premix (nequinate)558.365
    091-260PULVEX WORM CAPS (piperazine phosphate monohydrate)520.1804
    097-258PURINA BAN-WORM for Pigs (pyrantel tartrate)558.485
    102-942PULVEX Multipurpose Worm Caps (dichlorophene, toluene)520.580
    113-748PURINA PIGEMIA Oral (iron dextran complex)520.1182
    135-941CHECK-R-TON BM (pyrantel tartrate)558.485
    136-116PURINA WORM-A-RESTTM Litter Pack Premix (fenbendazole)520.905d
    140-869PURINA SAF-T-BLOC BG Medicated Feed Block (poloxalene, 6.6%)520.1840

    Therefore, under authority delegated to the Commissioner of Food and Drugs, and in accordance with § 514.116 Notice of withdrawal of approval of application (21 CFR 514.116), notice is given that approval of NADAs 011-779, 040-205, 042-116, 043-215, 046-700, 091-260, 097-258, 102-942, 113-748, 135-941, 136-116, and 140-869, and all supplements and amendments thereto, is hereby withdrawn, effective October 9, 2018.

    Elsewhere in this issue of the Federal Register, FDA is amending the animal drug regulations to reflect the voluntary withdrawal of approval of these applications.

    Start Signature

    Dated: September 24, 2018.

    Leslie Kux,

    Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2018-21147 Filed 9-27-18; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Effective Date:
10/9/2018
Published:
09/28/2018
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Notification of withdrawal.
Document Number:
2018-21147
Dates:
Withdrawal of approval is effective October 9, 2018.
Pages:
48950-48950 (1 pages)
Docket Numbers:
Docket No. FDA-2018-N-0002
PDF File:
2018-21147.pdf
CFR: (4)
21 CFR 520
21 CFR 522
21 CFR 524
21 CFR 558